Class of 2026
For vital contributions to defining the interplay between the microbiome, oncogenic signaling, and tumor immunity, including the elucidation of microbiome-mediated determinants of immunotherapy response, mechanisms of targeted therapy resistance in melanoma, and the identification of immune biomarkers capable of predicting clinical outcomes.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]